AACR 2023 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

AACR 2023 Conference Coverage

Videos

Playback speed

10 seconds

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Antibody Targeting EGFR and LGR5, in Advanced HNSCC

By AACR 2023 Conference Coverage FEATURING Ezra Cohen

206 views

May 18, 2023

Comments 0

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Videos

Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clin…

AACR 2023 Conference Coverage

M. Gouda

126 views

Clinical Activity of MCLA-158 (Petosemtamab), an IgG1 Bispecific Ant…

AACR 2023 Conference Coverage

E. Cohen

206 views

Understanding the Disease Biology of B-ALL: Insights From Genomic an…

AACR 2023 Conference Coverage

I. Iacobucci

60 views

Safety & Efficacy From the Phase 1/2 First-in-Human Study of REGN545…

AACR 2023 Conference Coverage

A. Suvannasankha

180 views

AACR 2023 on KEYNOTE-966 Phase 3 Study: Pembro in Combination With G…

AACR 2023 Conference Coverage

K. Kelley

352 views

A Personalized Cancer Vaccine mRNA-4157 + Pembro vs. Pembro in Resec…

AACR 2023 Conference Coverage

J. Weber

341 views

First-in-Class, First-in-Human Phase 1 Trial of VT3989, an Inhibitor…

AACR 2023 Conference Coverage

T. Yap

61 views